Surprisingly, we found that genetic ablation of IL-23 resulted in reduction of IFNγ-producing ILCs but not T cells during C. jejuni infection suggesting that ILCs can contribute to colitis development by IFNγ production during early stages of infection. The gene discussed is IFNG; the disease is colitis.